Update on anti-coagulation in atrial fibrillation

  • Jorg Kreuzer
  • Published 2011 in
    QJM : monthly journal of the Association of…

Abstract

Atrial fibrillation (AF), the most common clinically relevant arrhythmia, affects 2.2 million individuals in the USA and 4.5 million in Europe, resulting in significant morbidity and mortality. Pharmacotherapy aimed at controlling both heart rate and rhythm is employed to relieve AF symptoms, though debate continues about which approach is preferable. AF… (More)
DOI: 10.1093/qjmed/hcr107

Topics

7 Figures and Tables

Cite this paper

@inproceedings{Kreuzer2011UpdateOA, title={Update on anti-coagulation in atrial fibrillation}, author={Jorg Kreuzer}, booktitle={QJM : monthly journal of the Association of Physicians}, year={2011} }